1. Home
  2. ASRT vs OCCI Comparison

ASRT vs OCCI Comparison

Compare ASRT & OCCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASRT
  • OCCI
  • Stock Information
  • Founded
  • ASRT 1995
  • OCCI N/A
  • Country
  • ASRT United States
  • OCCI United States
  • Employees
  • ASRT N/A
  • OCCI N/A
  • Industry
  • ASRT Biotechnology: Pharmaceutical Preparations
  • OCCI Trusts Except Educational Religious and Charitable
  • Sector
  • ASRT Health Care
  • OCCI Finance
  • Exchange
  • ASRT Nasdaq
  • OCCI Nasdaq
  • Market Cap
  • ASRT 57.9M
  • OCCI 160.5M
  • IPO Year
  • ASRT 1997
  • OCCI N/A
  • Fundamental
  • Price
  • ASRT $0.69
  • OCCI $6.28
  • Analyst Decision
  • ASRT Strong Buy
  • OCCI
  • Analyst Count
  • ASRT 2
  • OCCI 0
  • Target Price
  • ASRT $3.25
  • OCCI N/A
  • AVG Volume (30 Days)
  • ASRT 259.0K
  • OCCI 115.8K
  • Earning Date
  • ASRT 08-06-2025
  • OCCI 12-11-2023
  • Dividend Yield
  • ASRT N/A
  • OCCI 24.32%
  • EPS Growth
  • ASRT N/A
  • OCCI N/A
  • EPS
  • ASRT N/A
  • OCCI N/A
  • Revenue
  • ASRT $119,001,000.00
  • OCCI N/A
  • Revenue This Year
  • ASRT N/A
  • OCCI N/A
  • Revenue Next Year
  • ASRT $11.91
  • OCCI $10.19
  • P/E Ratio
  • ASRT N/A
  • OCCI N/A
  • Revenue Growth
  • ASRT N/A
  • OCCI N/A
  • 52 Week Low
  • ASRT $0.51
  • OCCI $5.47
  • 52 Week High
  • ASRT $1.80
  • OCCI $10.15
  • Technical
  • Relative Strength Index (RSI)
  • ASRT 64.38
  • OCCI 53.05
  • Support Level
  • ASRT $0.63
  • OCCI $6.21
  • Resistance Level
  • ASRT $0.67
  • OCCI $6.30
  • Average True Range (ATR)
  • ASRT 0.03
  • OCCI 0.08
  • MACD
  • ASRT 0.01
  • OCCI 0.02
  • Stochastic Oscillator
  • ASRT 86.37
  • OCCI 94.05

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

About OCCI OFS Credit Company Inc.

OFS Credit Co Inc is a non-diversified, closed-end management investment company. Its investment objective is to generate current income, with a secondary objective to generate capital appreciation primarily through investment in collateralized loan obligation (CLO) equity and debt securities. The company invests in floating rate credit instruments and other structured credit investments, including; collateralized loan obligation (CLO) debt and subordinated (i.e., residual or equity) securities; traditional corporate credit investments, including leveraged loans and high yield bonds; opportunistic credit investments, including stressed and distressed credit situations and long/short credit investments; and other credit-related instruments.

Share on Social Networks: